227 related articles for article (PubMed ID: 30232528)
1. Effect of γ-hydroxybutyrate (GHB) on driving as measured by a driving simulator.
Liakoni E; Dempsey DA; Meyers M; Murphy NG; Fiorentino D; Havel C; Haller C; Benowitz NL
Psychopharmacology (Berl); 2018 Nov; 235(11):3223-3232. PubMed ID: 30232528
[TBL] [Abstract][Full Text] [Related]
2. Rate of elimination of γ-hydroxybutyrate from blood determined by analysis of two consecutive samples from apprehended drivers in Norway.
Årnes M; Bachs L; Sammarai MA; Jones AW; Høiseth G
Forensic Sci Int; 2020 Sep; 314():110374. PubMed ID: 32604006
[TBL] [Abstract][Full Text] [Related]
3. Ultra-high-performance liquid chromatography tandem mass spectrometry determination of GHB, GHB-glucuronide in plasma and cerebrospinal fluid of narcoleptic patients under sodium oxybate treatment.
Tittarelli R; Pichini S; Pedersen DS; Pacifici R; Moresco M; Pizza F; Busardò FP; Plazzi G
Forensic Sci Int; 2017 May; 274():70-74. PubMed ID: 28139340
[TBL] [Abstract][Full Text] [Related]
4. The effects of gamma-hydroxybutyrate on the sleep of narcolepsy patients: a double-blind study.
Scrima L; Hartman PG; Johnson FH; Thomas EE; Hiller FC
Sleep; 1990 Dec; 13(6):479-90. PubMed ID: 2281247
[TBL] [Abstract][Full Text] [Related]
5. GHB and driving impairment.
Couper FJ; Logan BK
J Forensic Sci; 2001 Jul; 46(4):919-23. PubMed ID: 11451079
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.
Liechti ME; Quednow BB; Liakoni E; Dornbierer D; von Rotz R; Gachet MS; Gertsch J; Seifritz E; Bosch OG
Br J Clin Pharmacol; 2016 May; 81(5):980-8. PubMed ID: 26659543
[TBL] [Abstract][Full Text] [Related]
7. Effects of GHB On Psychomotor and Driving Performance.
Centola C; Giorgetti A; Zaami S; Giorgetti R
Curr Drug Metab; 2018; 19(13):1065-1072. PubMed ID: 29366411
[TBL] [Abstract][Full Text] [Related]
8. The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms.
J Toxicol Clin Toxicol; 2003; 41(2):131-5. PubMed ID: 12733850
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of gamma-hydroxybutyrate versus placebo in treating narcolepsy-cataplexy: double-blind subjective measures.
Scrima L; Hartman PG; Johnson FH; Hiller FC
Biol Psychiatry; 1989 Aug; 26(4):331-43. PubMed ID: 2669980
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of measures of impairment in real and simulated driving: Results from a randomized, placebo-controlled study.
Helland A; Jenssen GD; Lervåg LE; Moen T; Engen T; Lydersen S; Mørland J; Slørdal L
Traffic Inj Prev; 2016; 17(3):245-50. PubMed ID: 26147898
[TBL] [Abstract][Full Text] [Related]
11. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
[TBL] [Abstract][Full Text] [Related]
12. Sodium oxybate-induced sleep driving and sleep-related eating disorder.
Wallace DM; Maze T; Shafazand S
J Clin Sleep Med; 2011 Jun; 7(3):310-1. PubMed ID: 21677903
[TBL] [Abstract][Full Text] [Related]
13. Addicted to driving under the influence--a GHB/GBL case report.
Couper FJ; Logan BK
J Anal Toxicol; 2004 Sep; 28(6):512-5. PubMed ID: 15516306
[TBL] [Abstract][Full Text] [Related]
14. Gamma-hydroxybutyrate and ethanol effects and interactions in humans.
Thai D; Dyer JE; Benowitz NL; Haller CA
J Clin Psychopharmacol; 2006 Oct; 26(5):524-9. PubMed ID: 16974199
[TBL] [Abstract][Full Text] [Related]
15. Sodium oxybate-induced central sleep apneas.
Frase L; Schupp J; Sorichter S; Randelshofer W; Riemann D; Nissen C
Sleep Med; 2013 Sep; 14(9):922-4. PubMed ID: 23834969
[TBL] [Abstract][Full Text] [Related]
16. Driving under the influence of gamma-hydroxybutyrate (GHB).
Jones AW; Holmgren A; Kugelberg FC
Forensic Sci Med Pathol; 2008; 4(4):205-11. PubMed ID: 19291440
[TBL] [Abstract][Full Text] [Related]
17. Increases in Serum Growth Hormone Concentrations Associated with GHB Administration.
Brailsford AD; Bartlett C; Kicman AT; Cowan DA
J Anal Toxicol; 2017 Jan; 41(1):54-59. PubMed ID: 27744373
[TBL] [Abstract][Full Text] [Related]
18. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
Mansukhani MP; Kotagal S
Sleep Med; 2012 Jun; 13(6):606-10. PubMed ID: 22445591
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
Sleep; 2002 Feb; 25(1):42-9. PubMed ID: 11833860
[TBL] [Abstract][Full Text] [Related]
20. Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics.
Abanades S; Farré M; Segura M; Pichini S; Barral D; Pacifici R; Pellegrini M; Fonseca F; Langohr K; De La Torre R
Ann N Y Acad Sci; 2006 Aug; 1074():559-76. PubMed ID: 17105953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
